RE:Dr. Yo Interview positiveRevive is in a great position. The companies working on vaccines know they have to overcome and reduce considerably the numbers of serious to fatal side effects. In the past such vaccines for much less damaging viruses took years and several variations until they got it right. All RVV has to prove is that their cocktail of a safe drug, Bucillamine, is affective in reducing the inflammation in the lungs and other organs which would save scores of lives and be one of the go to theraputics available to doctors when their patients come down with the virus. RVV was given a quick push by the FDA because much of the drug's safe effectiveness in dealing with inflammation etc. has been proven already. Our industrious CEO sharply detected this not long after he took the helm of RVV. That was when I increased and loaded up big time with shares and made a bundle and am looking forward to making a much bigger bundle in the near future. GLTA